Skip to content
Bored Studies
RecruitingAccepts healthy volunteersPhase 1

Study of MAR002 in Healthy Men

Marea Therapeutics · NCT07195175

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–40 · Men only
Healthy volunteers
Accepted
Study type
Interventional · Phase 1
Target enrollment
45
US sites recruiting
1
Study start
August 11, 2025
Record last updated
January 12, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men

Being studied: MAR002; Placebo

Conditions: Acromegaly

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Willingness to provide written informed consent
  • Age 18 to 40
  • Weight 55 to 95 kg
  • Body mass index (BMI) 18 to 30 kg/m2
  • Healthy men

Exclusion Criteria

  • History of hypersensitivity to monoclonal antibodies or study drug
  • Participation in any other investigational drug study
  • History of cancer
  • Recent acute illness
  • Positive test for HIV, hepatitis B/C
  • History of substance abuse or nicotine use
  • Recent blood donation
  • History of pituitary disorder
  • Any condition that prevents the participant from complying with study procedures

Recruiting US locations

Study contacts (from the official record)

  • Andrew Lane · 415-766-3610 · mar-201-info@mareatx.com
Study of MAR002 in Healthy Men (NCT07195175) | Bored Studies